Mouse Anti-GPR101 Recombinant Antibody (CBFYH-0452) (CBMAB-H1327-FY)

Flak, M. B., Koenis, D. S., Gonzalez-Nunez, M., Chopo-Pizarro, A., & Dalli, J. (2023). Deletion of macrophage Gpr101 disrupts their phenotype and function dysregulating host immune responses in sterile and infectious inflammation. Biochemical Pharmacology, 207, 115348.

Franke, M., Daly, A. F., Palmeira, L., Tirosh, A., Stigliano, A., Trifan, E., ... & Trivellin, G. (2022). Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism. The American Journal of Human Genetics, 109(4), 553-570.

Bao, X. D., Lu, L., Zhu, H. J., Yao, Y., Feng, M., Wang, R. Z., ... & Lu, Z. L. (2022). Concurrent mutations of germline GPR101 and somatic USP8 in a pediatric giant pituitary ACTH adenoma: a case report. BMC Endocrine Disorders, 22(1), 152.

Elizabeth, M. S., Verkerk, A. J., Hokken-Koelega, A. C., Verlouw, J. A., Argente, J., Pfaeffle, R., ... & de Graaff, L. C. (2021). Congenital hypopituitarism in two brothers with a duplication of the ‘acrogigantism gene’GPR101: clinical findings and review of the literature. Pituitary, 24, 229-241.

Trivellin, G., Tirosh, A., Hernández-Ramírez, L. C., Gupta, T., Tsai-Morris, C. H., Faucz, F. R., ... & Stratakis, C. A. (2021). The X-linked acrogigantism-associated gene gpr101 is a regulator of early embryonic development and growth in zebrafish. Molecular and cellular endocrinology, 520, 111091.

Trivellin, G., Faucz, F. R., Daly, A. F., Beckers, A., & Stratakis, C. A. (2020). Hereditary endocrine tumours: current state-of-the-art and research opportunities: GPR101, an orphan GPCR with roles in growth and pituitary tumorigenesis. Endocrine-Related Cancer, 27(8), T87-T97.

Flak, M. B., Koenis, D. S., Sobrino, A., Smith, J., Pistorius, K., Palmas, F., & Dalli, J. (2020). GPR101 mediates the pro-resolving actions of RvD5 n-3 DPA in arthritis and infections. The Journal of clinical investigation, 130(1), 359-373.

Abboud, D., Daly, A. F., Dupuis, N., Bahri, M. A., Inoue, A., Chevigné, A., ... & Hanson, J. (2020). GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of Gs and Gq/11. Nature communications, 11(1), 4752.

Vasilev, V., Daly, A. F., Trivellin, G., Stratakis, C. A., Zacharieva, S., & Beckers, A. (2020). Hereditary endocrine tumours: Current state-of-the-art and research opportunities: The roles of AIP and GPR101 in familial isolated pituitary adenomas (FIPA). Endocrine-Related Cancer, 27(8), T77-T86.

Hou, Z. S., & Tao, Y. X. (2019). Mutations in GPR101 as a potential cause of X-linked acrogigantism and acromegaly. Progress in Molecular Biology and Translational Science, 161, 47-67.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols